blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1740181

EP1740181 - NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  14.09.2012
Database last updated on 03.09.2024
Most recent event   Tooltip14.09.2012Refusal of applicationpublished on 17.10.2012  [2012/42]
Applicant(s)For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Sprout Pharmaceuticals, Inc.
4208 Six Forks Road, Suite 1010
Raleigh, NC 27609 / US
[2012/21]
Former [2007/02]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  MC  NL  PL  PT  RO  SE  SI  SK  TR 
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Binger Str. 173
D-55216 Ingelheim / DE
For all designated states
Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road Ridgefield
Connecticut 06877 / US
For:DE 
Boehringer Ingelheim Pharma GmbH & Co.KG
Binger Strasse 173
55218 Ingelheim am Rhein / DE
Inventor(s)01 / MENDLA, Klaus
Dinlingerstr. 43
88400 Biberach / DE
02 / PYKE, Robert
900 Ridgebury Road
Ridgefield, CT 06877 / US
03 / EISENREICH, Wolfram
Saeulingstr. 34
80686 München / DE
04 / FRIEDL, Thomas
Hans-Liebherr-Str. 48/4
88416 Ochsenhausen / DE
 [2007/02]
Representative(s)Hally, Anna-Louise, et al
FRKelly
27 Clyde Road
Dublin D04 F838 / IE
[N/P]
Former [2012/23]Hally, Anna-Louise, et al
FRKelly
27 Clyde Road
Ballsbridge
Dublin 4 / IE
Former [2007/02]Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH & Co. KG Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date05736586.818.04.2005
[2007/02]
WO2005EP04081
Priority number, dateUS20040564662P22.04.2004         Original published format: US 564662 P
US20040631800P30.11.2004         Original published format: US 631800 P
[2007/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005102342
Date:03.11.2005
Language:EN
[2005/44]
Type: A1 Application with search report 
No.:EP1740181
Date:10.01.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 03.11.2005 takes the place of the publication of the European patent application.
[2007/02]
Search report(s)International search report - published on:EP03.11.2005
ClassificationIPC:A61K31/496, A61K45/06, A61P15/00
[2007/02]
CPC:
A61K31/496 (EP,KR,US); A61K31/428 (EP,US); A61K31/519 (EP,US);
A61K31/557 (EP,US); A61K45/06 (EP,US); A61P15/00 (EP);
A61P15/10 (EP); A61P15/12 (EP); A61P25/00 (EP);
A61P43/00 (EP) (-)
C-Set:
A61K31/496, A61K2300/00 (EP,US);
A61K31/557, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/02]
Extension statesAL22.11.2006
BA22.11.2006
HR22.11.2006
LV22.11.2006
MK22.11.2006
YU22.11.2006
TitleGerman:NEUE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON SEXUALSTÖRUNGEN II[2007/02]
English:NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II[2007/02]
French:NOUVELLES COMPOSITIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT DE TROUBLES SEXUELS II[2007/02]
Entry into regional phase22.11.2006National basic fee paid 
22.11.2006Designation fee(s) paid 
22.11.2006Examination fee paid 
Examination procedure22.11.2006Examination requested  [2007/02]
08.10.2007Despatch of a communication from the examining division (Time limit: M06)
25.07.2008Reply to a communication from the examining division
18.12.2009Despatch of a communication from the examining division (Time limit: M06)
04.08.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.10.2010Reply to a communication from the examining division
07.05.2012Cancellation of oral proceeding that was planned for 08.05.2012
08.05.2012Date of oral proceedings (cancelled)
29.05.2012Despatch of communication that the application is refused, reason: substantive examination [2012/42]
08.06.2012Application refused, date of legal effect [2012/42]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.10.2007
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
25.07.2008Request for further processing filed
25.07.2008Full payment received (date of receipt of payment)
Request granted
07.08.2008Decision despatched
Fees paidRenewal fee
02.05.2007Renewal fee patent year 03
02.05.2008Renewal fee patent year 04
04.05.2009Renewal fee patent year 05
30.01.2010Renewal fee patent year 06
02.05.2011Renewal fee patent year 07
23.03.2012Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP1256343  (BECK JUERGEN K DR [DE]) [X] 1,2,29,30,39 * paragraph [0022]; example 2; claims 19-23 *;
 [Y]EP1285658  (PFIZER PRODUCTORS INC [US]) [Y] 3,4,39,40,42-45 * page 6, line 23 - page 7, line 10 * * page 7, lines 50-57 *;
 [X]US2003060475  (BORSINI FRANCO [DE]) [X] 1,2,29,30,39 * paragraph [0009] * * paragraph [0026] *;
 [XY]WO03035072  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [X] 1,29,31,34-38 * page 1, paragraphs 4-6 * * page 3, paragraph 5; claim - * [Y] 3,4,39,40,42-45;
 [PX]WO2005007166  (PFIZER LTD [GB], et al) [PX] 1,2,29-39 * page 29, lines 1-20 * * page 21, line 12 - page 22, line 12 *;
 [A]  - FOURCROY JEAN L, "Female sexual dysfunction: Potential for pharmacotherapy.", DRUGS, (2003), vol. 63, no. 14, ISSN 0012-6667, pages 1445 - 1457, XP009050771 [A] 1-4,29-45 * page 1447 * * page 1449, column R, paragraph 2 - page 1454, column R, paragraph 5 *

DOI:   http://dx.doi.org/10.2165/00003495-200363140-00002
ExaminationWO0100224
 WO03007949
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.